Cancer Research Prevention Award  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nzula, S.
Right arrow Articles by Stott, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nzula, S.
Right arrow Articles by Stott, D. I.
[Cancer Research 63, 3275-3280, June 15, 2003]
© 2003 American Association for Cancer Research


Immunology

Antigen-driven Clonal Proliferation, Somatic Hypermutation, and Selection of B Lymphocytes Infiltrating Human Ductal Breast Carcinomas1

Sazini Nzula2, James J. Going and David I. Stott

Division of Immunology, Infection and Inflammation, and Division of Cancer Sciences and Molecular Pathology, University of Glasgow, Western Infirmary, Glasgow, G11 6NT, Scotland, United Kingdom

Infiltration of B lymphocytes into the tumor tissue of breast cancer patients is a common occurrence, but the role of these cells in the immune response to the tumor is unknown. Heavy B-cell infiltration in medullary breast carcinoma is well documented and associated with a more favorable prognosis, implying a positive role for the humoral immune response in elimination of tumor cells. Variable B-cell infiltration has also been detected in infiltrating ductal carcinomas of the breast, but little is known about the immunoglobulin gene repertoire of these tumor-infiltrating B lymphocytes and whether they are actively responding to a local stimulus or merely passive bystanders. We have therefore investigated the repertoire of B cells infiltrating four invasive ductal carcinomas. A group of 233 rearranged Ig VH genes was amplified, cloned, and sequenced from microdissected foci of infiltrating B cells. B cells within individual foci were polyclonal, and most were highly mutated. Several foci expressed dominant sets of V genes derived from B-cell clones. Some of these were found in more than one lymphoid cluster, indicating that B cells had migrated into the surrounding tissue and seeded new clusters. Analysis of the pattern of mutations in clonally related sets of Ig V genes expressed by tumor-infiltrating B cells shows that these cells are undergoing antigen-driven proliferation, somatic hypermutation, and affinity maturation in situ.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Zheng, J. Huang, Y. Mao, S. Liu, X. Sun, X. Zhu, T. Ma, L. Zhang, J. Ji, Y. Zhang, et al.
Immunoglobulin Gene Transcripts Have Distinct VHDJH Recombination Characteristics in Human Epithelial Cancer Cells
J. Biol. Chem., May 15, 2009; 284(20): 13610 - 13619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Willis, S. S. Mallozzi, S. J. Rodig, K. M. Cronk, S. L. McArdel, T. Caron, G. S. Pinkus, L. Lovato, K. L. Shampain, D. E. Anderson, et al.
The Microenvironment of Germ Cell Tumors Harbors a Prominent Antigen-Driven Humoral Response
J. Immunol., March 1, 2009; 182(5): 3310 - 3317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Schmidt, D. Bohm, C. von Torne, E. Steiner, A. Puhl, H. Pilch, H.-A. Lehr, J. G. Hengstler, H. Kolbl, and M. Gehrmann
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Cancer Res., July 1, 2008; 68(13): 5405 - 5413.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Knutson, Y. Dang, H. Lu, J. Lukas, B. Almand, E. Gad, E. Azeke, and M. L. Disis
IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice
J. Immunol., July 1, 2006; 177(1): 84 - 91.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Babbage, C. H. Ottensmeier, J. Blaydes, F. K. Stevenson, and S. S. Sahota
Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines.
Cancer Res., April 15, 2006; 66(8): 3996 - 4000.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Kotlan, P. Simsa, J.-L. Teillaud, W. H. Fridman, J. Toth, M. McKnight, and M. C. Glassy
Novel Ganglioside Antigen Identified by B Cells in Human Medullary Breast Carcinomas: The Proof of Principle Concerning the Tumor-Infiltrating B Lymphocytes
J. Immunol., August 15, 2005; 175(4): 2278 - 2285.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M.L. van Herpen, J. A.W.M. van der Laak, I. J. M. de Vries, J. H. van Krieken, P. C. de Wilde, M. G.J. Balvers, G. J. Adema, and P. H.M. De Mulder
Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor
Clin. Cancer Res., March 1, 2005; 11(5): 1899 - 1909.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Kemp, J. M. Moore, and T. S. Griffith
Human B Cells Express Functional TRAIL/Apo-2 Ligand after CpG-Containing Oligodeoxynucleotide Stimulation
J. Immunol., July 15, 2004; 173(2): 892 - 899.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. E. Mycielska and M. B. A. Djamgoz
Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease
J. Cell Sci., May 1, 2004; 117(9): 1631 - 1639.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.